Alector, Inc. (ALEC)
1.94
+0.10
(+5.43%)
USD |
NASDAQ |
Oct 19, 14:20
Alector Market Cap : 216.61M for Oct. 19, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 205.45M |
| October 15, 2026 | 213.26M |
| October 14, 2026 | 209.91M |
| October 13, 2026 | 208.80M |
| October 12, 2026 | 232.25M |
| October 09, 2026 | 232.25M |
| October 08, 2026 | 225.55M |
| October 07, 2026 | 214.38M |
| October 06, 2026 | 202.10M |
| October 05, 2026 | 222.20M |
| October 02, 2026 | 202.10M |
| October 01, 2026 | 207.68M |
| September 30, 2026 | 206.57M |
| September 29, 2026 | 208.80M |
| September 28, 2026 | 214.38M |
| September 25, 2026 | 217.73M |
| September 24, 2026 | 214.38M |
| September 23, 2026 | 225.55M |
| September 22, 2026 | 224.43M |
| September 21, 2026 | 215.50M |
| September 18, 2026 | 213.26M |
| September 17, 2026 | 206.57M |
| September 16, 2026 | 214.94M |
| September 15, 2026 | 227.22M |
| September 14, 2026 | 246.76M |
| Date | Value |
|---|---|
| September 11, 2026 | 238.95M |
| September 10, 2026 | 238.95M |
| September 09, 2026 | 253.46M |
| September 08, 2026 | 275.79M |
| September 04, 2026 | 274.68M |
| September 03, 2026 | 280.26M |
| September 02, 2026 | 303.71M |
| September 01, 2026 | 267.98M |
| August 31, 2026 | 252.34M |
| August 28, 2026 | 261.28M |
| August 27, 2026 | 266.86M |
| August 26, 2026 | 274.68M |
| August 25, 2026 | 263.51M |
| August 24, 2026 | 256.81M |
| August 21, 2026 | 263.51M |
| August 20, 2026 | 252.34M |
| August 19, 2026 | 271.33M |
| August 18, 2026 | 246.76M |
| August 17, 2026 | 228.90M |
| August 14, 2026 | 218.85M |
| August 13, 2026 | 227.78M |
| August 12, 2026 | 240.06M |
| August 11, 2026 | 233.36M |
| August 10, 2026 | 188.70M |
| August 07, 2026 | 198.75M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 7.988B |
| Oncolytics Biotech, Inc. | 62.73M |
| Sangamo Therapeutics, Inc. | 45.65M |
| Sarepta Therapeutics, Inc. | 1.871B |
| Anixa Biosciences, Inc. | 91.99M |
Market Cap Related Metrics
| PS Ratio | 15.18 |
| Price | 1.94 |
| Earnings Yield | -56.30% |